CREG2 Polyclonal Antibody

PTM:It is not sure whether N-glycosylation is on Asn-165 and/or Asn-166.,Belongs to the CREG family.,tissue specificity:Brain specific mainly in the limbic system and faintly in the spinal cord but not in cerebellum.,

The CREG2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CREG2 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques, ensuring its exceptional sensitivity and specificity.

The CREG2 Polyclonal Antibody exhibits a strong affinity towards the CREG2 protein, enabling accurate and precise identification of its presence in cells and tissues. This antibody has been extensively validated through rigorous testing, guaranteeing its consistent and reproducible performance.

With its exceptional performance characteristics, the CREG2 Polyclonal Antibody is an invaluable asset for researchers and scientists involved in the study of CREG2 protein function and its role in various physiological and pathological processes. Its application extends to a wide range of research areas, including but not limited to cancer biology, developmental biology, and neurobiology.

The CREG2 Polyclonal Antibody is supplied in a convenient and ready-to-use format, ensuring ease of use and minimizing experimental variability. Its high-quality formulation ensures long-term stability and reliability, allowing for multiple experiments and analyses without compromising performance.

In summary, the CREG2 Polyclonal Antibody is a superior research tool that offers exceptional sensitivity, specificity, and reliability for the detection and analysis of CREG2 protein expression. Its robust performance characteristics make it an indispensable tool for researchers seeking to unravel the intricate mechanisms underlying CREG2 protein function in various biological contexts.